Infliximab restores colonic barrier to adherent-invasive E. coli in Crohn’s disease via effects on epithelial lipid rafts

References

• Salim SY, Söderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:362–381.
   PubMed Web of Science ®Google Scholar
• Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 2004;286:G367–G376.
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Streutker C, Yang P-C, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor alpha. Gut. 2004;53:1817–1824.
   PubMed Web of Science ®Google Scholar
• Zeissig S, Bojarski C, Buergel N, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor alpha antibody treatment. Gut. 2004;53:1295–1302.
   PubMed Web of Science ®Google Scholar
• Fischer A, Gluth M, Pape U-F, et al. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2013;304:G970–G979.
   PubMed Web of Science ®Google Scholar
• Li Z, Arijs I, De Hertogh G, et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. Inflamm Bowel Dis. 2010;16:1299–1310.
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Olaison G, Peterson KH, et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut. 2002;50:307–313.
   PubMed Web of Science ®Google Scholar
• MacDonald TT, Hutchings P, Choy MY, et al. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol. 1990;81:301–305.
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405–1413.
   PubMed Web of Science ®Google Scholar
• Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80–93.
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124.
   PubMed Web of Science ®Google Scholar
• Keita AV, Gullberg E, Ericson A-C, et al. Characterization of antigen and bacterial transport in the follicle-associated epithelium of human ileum. Lab Invest. 2006;86:504–516.
   PubMed Web of Science ®Google Scholar
• Wallon C, Braaf Y, Wolving M, et al. Endoscopic biopsies in Ussing chambers evaluated for studies of macromolecular permeability in the human colon. Scand J Gastroenterol. 2005;40:586–595.
   PubMed Web of Science ®Google Scholar
• Moussata D, Goetz M, Gloeckner A, et al. Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut. 2011;60:26–33.
   PubMed Web of Science ®Google Scholar
• Herd H, Daum N, Jones AT, et al. Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano. 2013;7:1961–1973.
   PubMed Web of Science ®Google Scholar
• Rodal SK, Skretting G, Garred O, et al. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell. 1999;10:961–974.
   PubMed Web of Science ®Google Scholar
• Wallon C, Persborn M, Jönsson M, et al. Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis. Gastroenterology. 2011;140:1597–1607.
   PubMed Web of Science ®Google Scholar
• Clark EC, Patel SD, Chadwick PR, et al. Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate. Gut. 2003;52:224–230.
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Yang P-C, Ceponis P, et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology. 2002;123:1099–1108.
   PubMed Web of Science ®Google Scholar
• Suenaert P, Bulteel V, Vermeire S, et al. Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent. Inflamm Bowel Dis. 2005;11:667–673.
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Satsu H, Shimizu M. Signaling pathways involved in tumor necrosis factor alpha-induced upregulation of the taurine transporter in Caco-2 cells. FEBS Lett. 2005;579:3069–3074.
   PubMed Web of Science ®Google Scholar
• Su L, Nalle SC, Shen L, et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology. 2013;145:407–415.
   PubMed Web of Science ®Google Scholar
• Wine E, Ossa JC, Gray-Owen SD, et al. Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol. 2009;9:180.
   PubMed Web of Science ®Google Scholar
• Keita AV, Salim SY, Jiang T, et al. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. J Pathol. 2008;215:135–144.
   PubMed Web of Science ®Google Scholar
• Salim SY, Silva MA, Keita AV, et al. CD83 + CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer’s patches of ileal Crohn’s disease. Am. J. Pathol. 2009;174:82–90.
   PubMed Web of Science ®Google Scholar
• Haller D, Russo MP, Sartor RB, et al. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem. 2002;277:38168–38178.
   PubMed Web of Science ®Google Scholar
• Fries W, Renda MC, Lo Presti MA, et al. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn’s disease in Southern Italy. Am J Gastroenterol. 2005;100:2730–2736.
   PubMed Web of Science ®Google Scholar
• Sun J, Hobert ME, Rao AS, et al. Bacterial activation of beta-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol. 2004;287:G220–G227.
   PubMed Web of Science ®Google Scholar
• Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest. 2002;110:597–603.
   PubMed Web of Science ®Google Scholar
• Li X, Leu S, Cheong A, et al. Akt2, phosphatidylinositol 3-kinase, and PTEN are in lipid rafts of intestinal cells: role in absorption and differentiation. Gastroenterology 2004;126:122–135.
   PubMed Web of Science ®Google Scholar
• Wooldridge KG, Williams PH, Ketley JM. Host signal transduction and endocytosis of Campylobacter jejuni. Microb. Pathog. 1996;21:299–305.
   PubMed Web of Science ®Google Scholar
• Baorto DM, Gao Z, Malaviya R, et al. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 1997;389:636–639.
   PubMed Web of Science ®Google Scholar
• Bowie RV, Donatello S, Lyes C, et al. Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2012;302:G781–G793.
   PubMed Web of Science ®Google Scholar